Discovery of a Highly Potent, Selective, and Bioavailable Soluble Epoxide Hydrolase Inhibitor with Excellent Ex Vivo Target Engagement
- 31 July 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (16), 5009-5012
- https://doi.org/10.1021/jm900725r
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Orally Bioavailable Potent Soluble Epoxide Hydrolase InhibitorsJournal of Medicinal Chemistry, 2007
- Emerging role of epoxyeicosatrienoic acids in coronary vascular functionEuropean Journal of Clinical Investigation, 2006
- An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive HypertensionHypertension, 2005
- Epoxide hydrolases: their roles and interactions with lipid metabolismProgress in Lipid Research, 2005
- Epoxyeicosatrienoic acids (EETs): metabolism and biochemical functionProgress in Lipid Research, 2003
- Endothelium-Derived Hyperpolarizing Factor in Human Internal Mammary Artery Is 11,12-Epoxyeicosatrienoic Acid and Causes Relaxation by Activating Smooth Muscle BK Ca ChannelsCirculation, 2003
- Epoxide hydrolases: biochemistry and molecular biologyChemico-Biological Interactions, 2000
- Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic AcidsCirculation Research, 2000
- Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived EicosanoidsScience, 1999
- Proinflammatory Mediators Chronically Downregulate the Formation of the Endothelium-Derived Hyperpolarizing Factor in Arteries Via a Nitric Oxide/Cyclic GMP–Dependent MechanismCirculation, 1999